Skip to main content
logo
Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India flag India · Delayed Price · Currency is INR
78.39
+0.92 (1.19%)
At close: Jul 31, 2026

BOM:524412 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4,7234,7234,7394,0264,1904,929
Revenue Growth
-0.35%-0.35%17.73%-3.91%-15.01%40.27%
Gross Profit
177.62177.62118.23206.4150.87208.51
Operating Income
43.1943.1951.1597.7166.92100.27
Net Income
39.6839.6840.2446.8437.7165.55
Earnings Per Share
1.391.391.421.841.482.72
EPS Growth
-2.11%-2.11%-22.83%24.32%-45.59%-2.36%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
33.9833.9832.2928.911.241.92
Total Debt
607.49607.49435.49313.52377.18141.63
Net Cash (Debt)
-573.51-573.51-403.2-284.63-365.94-139.71
Net Cash Growth
------
Net Cash Per Share
-20.16-20.16-14.27-11.20-14.36-5.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
101.39101.39103-29.94-12.814.99
Capital Expenditures
-124.11-124.11-52.04-7.22-10.44-22.01
Free Cash Flow
-22.72-22.7250.96-37.16-23.25-17.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
3.76%3.76%2.50%5.13%3.60%4.23%
Operating Margin
0.91%0.91%1.08%2.43%1.60%2.03%
Pretax Margin
1.15%1.15%1.29%1.33%1.43%2.04%
Profit Margin
0.84%0.84%0.85%1.16%0.90%1.33%
FCF Margin
-0.48%-0.48%1.07%-0.92%-0.56%-0.34%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
56.4036.4923.4226.7615.9316.03
P/FCF Ratio
--18.49---
PS Ratio
0.470.310.200.310.140.21